| Date | Time | Source | Headline | Symbol | Company |
| 06/10/2006 | 1:15PM | PR Newswire (US) | BYETTA(R) Shown to Reduce Blood Glucose Levels When Added to Patients Using a TZD | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/10/2006 | 11:00AM | PR Newswire (US) | Late Breaking Data at ADA 2006 Shows Amylin-Leptin Co-Administration Reduces Body Weight and Body Fat in Animal Studies | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/10/2006 | 11:00AM | PR Newswire (US) | BYETTA(R) Extension Study Shows Sustained Improvements in Blood Glucose Control and Progressive Weight Loss After Two Years | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/10/2006 | 11:00AM | PR Newswire (US) | Study Demonstrated Once-Weekly Exenatide LAR Improved Glucose Control in Patients with Type 2 Diabetes | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2006 | 5:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/07/2006 | 5:15PM | PR Newswire (US) | Amylin Pharmaceuticals Promotes Daniel M. Bradbury to President and Chief Operating Officer | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/06/2006 | 5:05PM | PR Newswire (US) | Amylin Pharmaceuticals Demonstrates Progress Across Diabetes and Obesity Portfolios at ADA 2006 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/25/2006 | 5:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Friedman Billings Ramsey Growth Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/15/2006 | 12:17PM | PR Newswire (US) | Seven Summits Research Releases Comments on GOOG, BRCM, CVS, JBLU, and AMLN | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/10/2006 | 5:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders and Bank of America Health Care Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/01/2006 | 5:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/26/2006 | 5:05PM | PR Newswire (US) | Amylin Pharmaceuticals Reports First Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/20/2006 | 8:00AM | PR Newswire (US) | Amylin Pharmaceuticals Announces BYETTA Revenue | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/04/2006 | 7:30AM | PR Newswire (US) | Amylin Pharmaceuticals Announces Exercise of Over-Allotment Option by Underwriters | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/30/2006 | 7:30AM | PR Newswire (US) | Amylin Pharmaceuticals Announces Public Offering of Common Stock | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/28/2006 | 8:15AM | PR Newswire (US) | Amylin Pharmaceuticals Elects Steven Altman to Board of Directors | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/27/2006 | 7:30AM | PR Newswire (US) | Amylin Pharmaceuticals Announces Public Offering of Common Stock | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/24/2006 | 7:15AM | PR Newswire (US) | Once-Weekly Exenatide LAR Clinical Study in Type 2 Diabetes Initiated | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/21/2006 | 10:48AM | PR Newswire (US) | William Blair & Company Initiates Coverage of Amylin Pharmaceuticals, Inc. With Market Perform Rating | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/17/2006 | 9:01AM | PR Newswire (US) | Seven Summits Research Releases Alerts on NTAP, AMLN, CTXS, USB, and CTAS | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/02/2006 | 4:52PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Cowen & Co. Health Care Conference and Lehman Brothers Global Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/01/2006 | 4:15PM | PR Newswire (US) | Supplemental New Drug Application for BYETTA Submitted to FDA for Use With TZDs | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/22/2006 | 4:40PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Citigroup Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/10/2006 | 9:14AM | PR Newswire (US) | MORNING UPDATE: Seven Summits Research Issues Alerts MFE, MET, CVH, ACI, and AMLN | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/09/2006 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals Reports 2005 Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/09/2006 | 4:05PM | PR Newswire (US) | Pramlintide Obesity Study Results Positive | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/02/2006 | 1:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Year-End Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/26/2006 | 6:30AM | PR Newswire (US) | Amylin Pharmaceuticals Announces BYETTA Revenue | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/09/2006 | 7:15AM | PR Newswire (US) | Amylin Pharmaceuticals Added to the NASDAQ-100 Index | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/06/2006 | 1:22PM | PR Newswire (US) | Amylin Pharmaceuticals, Inc. to Join the NASDAQ-100 Index Beginning January 9, 2006 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |